Fraunhofer MEVIS among Winners of InnoHealth USA 2021

Fraunhofer MEVIS is among the winning teams of the call for Ideas & Innovation of the InnoHealth USA 2021 campaign. Nine Research-SME-Tandems and their innovative projects are invited to join the Matchmaking Tour USA and the Idea2Project Workshop.

©metamorworks - stock.adobe.com

The project Patho AI & Image Fusion represented by Fraunhofer MEVIS researcher Johannes Lotz and Felix Faber from MindPeak GmbH focuses on histological tissue-analysis using image fusion and AI technology. In this project, artificial intelligence (AI) is applied along with fusion of multiple images to correlate tissue structures and automate clinical diagnoses in histopathology. Image fusion allows faster and more precise training of AI models and can also be used to combine multiple stains. The tissue analysis software discriminates between tumor and non-tumor cells and finds regions of inflammatory cell infiltration and abnormal structures indicating cancer or other diseases.

InnoHealth USA is a campaign led by the Fraunhofer-Gesellschaft as part of the initiative Research in Germany funded by the Federal Ministry of Education and Research (BMBF). The campaign, adressing small and medium-sized enterprises (SME) and start-ups in the field of digital health, aims to connect the U.S. and German healthcare research sectors, to build networks and to identify areas for deeper collaboration for mutual benefit.

Weitere News

Unterzeichnung MoU, v.l.n.r.: Matthias Wilmans, Arik Willner, Helmut Dosch, Matthias Rehahn, Axel Müller-Groeling, und Hans-Otto Feldhütter (Bild: DESY)
Unterzeichnung MoU, v.l.n.r.: Matthias Wilmans (Niederlassungsleiter Hamburg EMBL), Arik Willner (CTO DESY), Helmut Dosch (Vorsitzender des Direktoriums DESY), Matthias Rehahn (Wissenschaftlich-technische Geschäftsführer Hereon), Axel Müller-Groeling (Vorstand für Forschungsinfrastrukturen und Digitalisierung der Fraunhofer-Gesellschaft), und Hans-Otto Feldhütter (Direktor Forschungsinfrastrukturen und Nachhaltigkeit der Fraunhofer-Gesellschaft) (Bild: DESY)

Kooperation für Forschung und Industrie

Von neuen Methoden der Bildgebung über neue Datenformate und -analysen bis hin zum Screening von Wirkstoffen und Biomaterialien: Das Potenzial von Synchrotronstrahlung auch für die ...

Weiterlesen …
GerdGeisslinger_(C) Fraunhofer IME_Krentz Photography Aachen

Interview mit Prof Geißlinger, Fraunhofer IME

Prof. Dr. Gerd Geißlinger, Institutsleiter des Fraunhofer-Instituts für Mo­le­ku­lar­bio­lo­gie und Angewandte Oekologie IME und Ge­sund­heits­for­schungs­be­auf­trag­ter der Fraunhofer-Gesellschaft über die aktuelle SARS-CoV-2-Pandemie und darüber, was Fraunhofer ...

Weiterlesen …